ArticleScientific reports2025
Serological data indicate a widespread presence of rabbit haemorrhagic disease in rabbit farms in Algeria.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
The Algerian government has recently supported plans to develop and increase commercial rabbit farming. A necessary condition for their success is to ensure rabbits' health and protect farms from infectious diseases. Among these, Rabbit Haemorrhagic Disease (RHD) is one of the worst, causing high mortality and, thus, severe economic losses. Considering RHD's high diffusibility, accurate surveillance systems and the proper and extensive use of vaccinal prevention are paramount in protecting rabbit populations. A sero-epidemiological survey on RHD was conducted in 19 herds located in different regions of Algeria to obtain a first overview of the monitoring system's ability to detect RHD and estimate its presence and distribution in the country. The results showed that RHD is widespread in Algeria, far more than assumed based on the number of reported and diagnosed disease outbreaks. As in the rest of the world, RHDV2 was by far the prevalent, if not the only, agent of RHD in Algeria. By verifying the outcomes and results of using RHD vaccine in farms, it was shown the need to improve vaccination plans, likely through the strict application of the guidelines for RHD direct prophylaxis provided by the EU Lagmed project.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.